enfortumab,vedolizumab
takeda,seagen,astellas
['bladder', 'enfortumab', 'mibc', ' vedo', 'vedo', 'nmibc']
happy to present exciting news from #asco23 ! enfortumab vedotin, a groundbreaking treatment for bcg-refractory nmibc, showcased in its world debut as intravesical therapy! promising safety data and potential hope for patients seeking effective options. #bladdercancer 
Professor of Urology @HopPitieSalpe @APHP @Sorbonne_Univ_ Paris France 🇫🇷 Editor-in-Chief @EurUrolOncol @Uroweb & CCAFU chairman @AFUrologie - Views my own